PCN11 PHARMACOECONOMIC ANALYSES OF ERLOTINIB COMPARED WITH BEST SUPPORTIVE CARE (BSC) FOR THE TREATMENT OF RELAPSED NON-SMALL CELL LUNG CANCER (NSCLC) FROM THE CANADIAN PUBLIC HEALTH CARE PERSPECTIVE - Concepedia

Concepedia

Publication | Open Access

PCN11 PHARMACOECONOMIC ANALYSES OF ERLOTINIB COMPARED WITH BEST SUPPORTIVE CARE (BSC) FOR THE TREATMENT OF RELAPSED NON-SMALL CELL LUNG CANCER (NSCLC) FROM THE CANADIAN PUBLIC HEALTH CARE PERSPECTIVE

DOI Full Paper Access

16

Citations

0

References

2006

Year

Isabelle Côté, N. B. Leighl, Marlene Gyldmark, Bridget Maturi

Value in Health

MedicineCancer ManagementPharmacologyPharmacotherapyCancer TreatmentOncologyLung Cancer

No additional data available for this publication yet. Check back later!